About Us | Contact Us |        

Psoriatic Arthritis: Optimizing Approaches to Recognition and Management

Psoriatic Arthritis: Optimizing Approaches to Recognition and Management
0.75 AMA PRA Category 1 Credit(s)
Launch Date:
November 11, 2016
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

Dermatologists and rheumatologists

Relevant Terms:

Psoriatic Arthritis

Jose U. Scher, MD

Jose U. Scher, MD
Assistant Professor Medicine (Rheumatology)
New York University School of Medicine
New York, NY

Jose U. Scher, MD, is assistant professor in the Department of Medicine at New York University (NYU) Langone Medical Center. He serves as director of the Arthritis Clinic at NYU-Hospital for Joint Diseases, the Psoriatic Arthritis Center at NYU Langone Medical Center, and the Microbiome Center for Rheumatology and Autoimmunity at NYU School of Medicine. 
As the director of the Psoriatic Arthritis Center, Dr. Scher oversees patient care, education, and translational research initiatives in psoriatic arthritis. His main area of research is related to the role of the human microbiome in autoimmune and rheumatic disease, specifically in psoriasis, psoriatic arthritis, and rheumatoid arthritis.
1. Differentiate between psoriatic arthritis (PsA) and other arthritides to ensure early and accurate diagnosis of PsA
2. Appropriately incorporate the various disease modifying agents into the management of patients with PsA taking into consideration patient comorbidities
3. Utilize effective communication and collaboration techniques to foster clinical care coordination among care team members
4. Integrate shared decision-making techniques to improve patients' understanding of the risks and benefits of their treatments and to allow them to participate in healthcare decisions

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and RMEI Medical Education, LLC. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The University of Cincinnati designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

According to the disclosure policy of the University of Cincinnati College of Medicine, all faculty, planning committee members, and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interest related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. Disclosure will be made at the time of activity.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
  • Jose U. Scher, MD, has affiliations with AbbVie and Novartis (Consulting Fees); and Janssen (Advisory Board).
University of Cincinnati
  • Susan P. Tyler, MEd, CMP, CHCP, CME Director, has no affiliations with commercial interests relative to the content to disclose.
  • Rick Ricer, MD, CME Physician Reviewer, has no affiliations with commercial interests relative to the content to disclose.
RMEI Medical Education, LLC
  • Joanne M. Faysal, MS, has no affiliations with commercial interests relative to the content to disclose.
  • Jacqui Brooks, MBBCh, MRCPsych, has no affiliations with commercial interests relative to the content to disclose
  • Amy Reeve has no affiliations with commercial interests relative to the content to disclose.
The opinions expressed during the enduring activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees’ professional development.
Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.
Estimated time to complete: 0.75 hours
Medium: Internet

There is no fee for this educational activity.

This activity is supported by independent educational grants from AbbVie, Lilly, and UCB.  

By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive up to 0.75 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page. Users must:
  • Read the learning objectives and faculty disclosures.
  • Participate in the activity.
  • Complete the activity post-test and evaluation.
Physicians, nurse practitioners, and physician assistants who successfully complete the post-test and evaluation will receive CME credit. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation. You must score 70% or higher on the post-test to receive credit for this activity.  Participants have three attempts to successfully pass the post-test.
Supported Browsers:
Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above